Protara Therapeutics, Inc. (TARA)
3.88
+0.03
(+0.78%)
USD |
NASDAQ |
Aug 24, 16:00
3.88
0.00 (0.00%)
After-Hours: 20:00
Protara Therapeutics Debt to Equity Ratio : 0.017 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.017 |
| March 31, 2026 | 0.0169 |
| December 31, 2025 | 0.0171 |
| September 30, 2025 | 0.0276 |
| June 30, 2025 | 0.0273 |
| March 31, 2025 | 0.0267 |
| December 31, 2024 | 0.0268 |
| September 30, 2024 | 0.0579 |
| June 30, 2024 | 0.0541 |
| March 31, 2024 | 0.0895 |
| December 31, 2023 | 0.08 |
| September 30, 2023 | 0.0741 |
| June 30, 2023 | 0.0696 |
| March 31, 2023 | 0.065 |
| December 31, 2022 | 0.0625 |
| September 30, 2022 | 0.0474 |
| June 30, 2022 | 0.0469 |
| March 31, 2022 | 0.0462 |
| December 31, 2021 | 0.0447 |
| September 30, 2021 | 0.0437 |
| June 30, 2021 | 0.0429 |
| March 31, 2021 | 0.0057 |
| December 31, 2020 | 0.0055 |
| September 30, 2020 | 0.0041 |
| June 30, 2020 | 0.0225 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0264 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0072 |
| March 31, 2019 | 0.0092 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.845 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| NovelStem International Corp. | -0.8748 |
| Brainstorm Cell Therapeutics, Inc. | -0.1185 |
| Summit Therapeutics, Inc. | 0.0324 |
| Kezar Life Sciences, Inc. | 0.0208 |
| Clene, Inc. | -0.9018 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 176.09M |
| Total Liabilities (Quarterly) | 14.78M |
| Shareholders Equity (Quarterly) | 161.31M |
| Current Ratio | 10.97 |
| Net Debt Paydown Yield | 0.13% |